Clinical Trial Update: Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

Clinical Trial Update describing safety, pharmacokinetics and pharmacodynamics relationships of RLS-0071 in patients with acute exacerbation of chronic obstruct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Exacerbation of Chronic Obstructive Pulmonary Disease

Drugs mentioned

• RLS-0071 (RLS-0071)

Snippet

Sponsor: ReAlta Life Sciences, Inc. | Conditions: Acute Exacerbation of Chronic Obstructive Pulmonary Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING